Vertos Medical
Vertos Medical specializes in developing minimally invasive treatments for lumbar spinal stenosis (LSS) using their proprietary mild® Procedure, which is designed to restore space in the spinal canal through a small incision and offers lasting pain relief and increased mobility.
Services
Vertos Medical specializes in developing minimally invasive treatments for lumbar spinal stenosis (LSS). Their primary offering is the mild® Procedure, an outpatient technique designed to restore space in the spinal canal through a minimal incision. The procedure typically takes less than an hour and can be done using local anesthetic and light sedation. Vertos Medical partners with leading medical institutions and national medical societies to ensure that patients have access to their treatment options.
Products
Vertos Medical's flagship product is the mild® Procedure. This proprietary technology is designed to remove excess ligament tissue to restore space in the spinal canal, addressing a major root cause of LSS. The mild® Procedure does not require general anesthesia, implants, stitches, steroids, or opioids. Patients typically receive lasting pain relief and increased mobility, and the procedure leaves no implants behind, requiring only a simple Band-Aid post-operation.
History
Vertos Medical has established itself as a leader in the treatment of lumbar spinal stenosis through continuous innovation and extensive clinical research. The company has conducted sixteen clinical trials and published more than 30 peer-reviewed articles demonstrating the efficacy and safety of the mild® Procedure. The procedure is FDA-cleared, covered nationwide by Medicare and Medicare Advantage, and has been performed on thousands of patients.
Headquarters
Vertos Medical is headquartered at 95 Enterprise #325, Aliso Viejo, CA 92656. From this location, the company oversees its comprehensive operations, including marketing, research, development, and planning for international expansion.
Clinical Trials and Research
Vertos Medical's mild® Procedure is supported by a robust portfolio of clinical research. The company has conducted sixteen clinical trials and published over 30 peer-reviewed articles that demonstrate the procedure's safety and efficacy. The mild® Procedure has a safety profile similar to epidural steroid injections but offers more lasting results, helping patients avoid back surgery for at least five years.